Loading clinical trials...
Loading clinical trials...
A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80,160 and 320mg ALD518 Versus Placebo Administered as Multiple IV Infusions to Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Conditions
Interventions
ALD518
Infusion without ALD518'
Locations
26
Canada
K-W Musculoskeletal Research, Inc.
Kitchener, Ontario, Canada
Rheumatology Research Associates
Ottawa, Ontario, Canada
V. Tsitlanadze Scientific Practical Centre of Rheumatology
Tbilisi, Georgia
Medulla Chemotherapy and Immunotherapy Clinic
Tbilisi, Georgia
Chanre Rheumatology and Immunology Center and Research
Malleshwaram, Bangalore, India
KLE Society Hospital and Medical Research Centre
Nehru Nagar, Belgaum, India
Start Date
October 1, 2008
Primary Completion Date
June 1, 2009
Completion Date
December 1, 2009
Last Updated
July 9, 2020
NCT07017686
NCT05038553
NCT05790356
NCT03429426
NCT06028438
NCT06800157
Lead Sponsor
CSL Behring
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions